Restless legs syndrome: A review

CNS Spectrums

Volumn 11, Issue 7, 2006, Pages 511-520

  Chahine, Lama M ^a   Chemali, Zeina N ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENZODIAZEPINE DERIVATIVE; CABERGOLINE; CARBAMAZEPINE; CODEINE; DEXTROPROPOXYPHENE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOT DERIVATIVE; GABAPENTIN; IRON; LEVODOPA; OPIATE DERIVATIVE; OXYCODONE; PERGOLIDE; PIRIBEDIL; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; TALIPEXOLE;

CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FAMILIAL DISEASE; GENE LOCUS; GENETIC LINKAGE; HEADACHE; HUMAN; IRON METABOLISM; LIMB MOVEMENT; NAUSEA; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SENSORIMOTOR FUNCTION; SIDE EFFECT; SLEEP DISORDER;

EID: 33746569535     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900013547     Document Type: Review

References (101)

1. Ekbom KA. Restless legs: clinical study of hitherto over-looked disease in legs characterized by peculiar parasthesia, pain, and weakness and occurring in two main forms, asthenia crurum parasthetica and asthenia crurum dolorosa. Acta Med Scand. 1945;58(suppl 1):1-123.
2. Gorman CA, Dyck PJ, Pearson JS. Symptom of restless legs. Arch Intern Med. 1965:115:155-159.
3. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001;18:128-147.
4. Dndo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology. 1996;47:1435-1441.
5. Phillips B. Movement disorders: a sleep specialist's perspective. Neurology. 2004;62(5 suppl 2):S9-S16.
6. Michaud M, Chabli A, Lavigne G, Montplaisir J. Arm restlessness in patients with, restless legs syndrom. Mov Disord. 2000;115:289-293.
7. Lutz EG. Restless legs, anxiety and caffeinism. J Clin Psychiatry. 1978;39:693-698.
8. Provini F, Vetrugno R, Meletti S, et al. Motor pattern of periodic limb movements during sleep. Neurology. 2001;57:300-304.
9. Tan Ek, Dndo WG. Motor restlessness. Int J Clin Pract. 2001;55:320-322.
10. Hening W, Walters AS, Allen RR Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5:237-246.
11. Michaud M, Dumont M. Selmaoui B, Paquet J, Fantini M, Montplaisir J. Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol. 2004;55:372-380.
12. Trenkwalder C, Hening WA, Walters AS, Campbell SS, Rahman K, Chokroverty S. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 1999;14:102-110.
13. Hening WA, Allen RP. Restless legs syndrome (RLS): the continuing development of diagnostic standards and severity measures. Sleep Med. 2003;4:95-97.
14. Allen RP, Earley CJ. Validation of the Johns Hopkins restless legs severity scale. Sleep Med. 2001;2:239-242.
15. Garcia-Borreguero D, Odin P, Serrano C. Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology. 2003;61(6 suppl 3):S49-S55.
16. Saletu B, Anderer R Saletu M, Hauer C, Lindeck-Pozza L, Saletu-Zyhlarz G. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep Med. 2002:(3 suppl):S35-S42.
17. Recording and scoring leg movements. The Atlas Task Force. Sleep. 1993;16:748-759.
18. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119.
19. Bastuji H, Garcia-Larrea L. Sleep/wake abnormalities in patients with periodic leg movements during sleep: factor analysis on data from 24-h ambulatory polygraphy. J Sleep Res. 1999;8:217-223.
20. Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med 2003;4:343-345.
21. Young JR, Humphries AW, DeWolfe VG. Restless leg syndrome. Geriatrics. 1969;24:167-171.
22. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001;16:1159-1163.
23. Mosko S, Zetin M, Glen S, et al. Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. J Clin Psychol. 1989;45:51-61.
24. Banno K, Delaive K, Walld R, Kryger MH. Restless legs syndrome in 218 patients: associated disorders. Steep Med. 2000;1:221-229.
25. Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther. 2004;26:925-935.
26. Walter AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
27. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000;54:1064-1068.
28. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160:2137-2141.
29. Tan EK, Seah A, See SJ, Lim E, Wong MC, Koh KK. Restless legs syndrome in an Asian population: A study in Singapore. Mov Disord. 2001;16:577-579.
30. Inoue Y, Ishizuka T, Arai H. Surveillance on epidemiology and treatment of restless legs syndrome in Japan. J New Rem Clin. 2000;49:244-254.
31. Bhowmik D, Bhatia M, Gupta S, Agarwal SK, Tiwari SC, Dash SC. Restless legs syndrome in hemodialysis patients in India: a case controlled study. Sleep Med. 2003;4:143-146.
32. Dhayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53:547-554.
33. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196-202.
34. Dndo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol. 2002;59:421-424.
35. Walters AS. Is there a subpopulation of children with growing pains who really have Restless Legs Syndrome? A review of the literature. Sleep Med. 2002;3:93-98.
36. Picchietti DL, England SJ, Walters AS, Willis K, Verrico T. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol. 1998;13:588-594.
37. Walters AS, Hickey K, Maltzman J, et al. A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey. Neurology. 1996;46:92-95.
38. Winklemann J, Muller-Myhsok B, Wittchen HU, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol. 2002;52:297-302.
39. Trenkwalder C, Seidel VC, Gasser T, Oertel WH. Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord. 1996;11:389-394.
40. Lazzarini A, Walters AS, Hickey K, et al. Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees. Mov Disord. 1999;14:111-116.
41. Bonati MT, Ferini-Strambi L, Aridon R Dldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps'on chromosome 14q. Brain. 2003;126(pt 6):1485-1492.
42. Dndo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology. 2000;55:1404-1406.
43. Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet. 2001;69:1266-1270.
44. Ferini-Strambi L, Bonati MT, Dldani A, Aridon P, Zucconi M, Casari G. Genetics in restless legs syndrome. Sleep Med. 2004;5:301-304.
45. Levchenko A, Montplaisir JY, Dube MP, et al. The 14q restless legs syndrome locus in the French Canadian population. Ann Neurol. 2004;55:887-891.
46. Chen S, Dndo WG, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scan identi-fies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet. 2004;74:876-885.
47. Desautels A, Turecki G, Montplaisir J, et al. Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology. 2002;59:215-219.
48. Desautels A, Turecki G, Montplaisir J, et al. Dopaminergic neurotransmission and rest-less legs syndrome: a genetic association analysis. Neurology. 2001;57:1304-1306.
49. Hening WA. Subjective and objective criteria in the diagnosis of the restless legs syndrome. Sleep Med. 2004:5:285-292.
50. Montplaisir J, Boucher S, Nicolas A, et al. Ilmmobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord. 1998;13:324-329.
51. D'Keeffe ST. Restless legs syndrome. A review. Arch Intern Med. 1996;156:243-248.
52. Walters AS, Hening WA, Chokroverty S. Frequent occurrence of myoclonus while awake and at rest, body rocking and marching in place in a subpopulation of patients with restless legs syndrom. Acta Neurol Scand. 1988;77:418-421.
53. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 2004;5:385-391.
54. Earley C. Restless Legs Syndrome. N Engl J Med 2003;348:2103-2109.
55. Manconi M, Govoni V, De Vito A, Economou NT, Cesnik E, Mollica G, Granieri E. Pregnancy as a risk factor for restless legs syndrome. Sleep Med. 2004;5:305-308.
56. Patel S. Restless legs syndrome and periodic limb movements of sleep: fact, fad, and fiction. Curr Opin Pulm Med. 2002;8:498-501.
57. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23:200-203.
58. Aul EA, Davis BJ, Rodnitzky RL. The importance of formal serum iron studies in the assessment of restless legs syndrome. Neurology. 1998;51:912-913.
59. Goodman JD, Brodie C, Ayida GA. Restless leg syndrome in pregnancy. BMJ. 1988;297:1101-1102.
60. Winkleman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996;28:372-378.
61. Tan EK, Ho SC, Eng P, et al. Restless legs symptoms in thyroid disorders. Parkinsonism Relat Disord. 2004;10:149-151.
62. Reynolds G, Slake DR, Pall HS, Williams A. Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed). 1986;292:659-660.
63. Salih AM, Gray RE, Mills KR, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol. 1994;33:60-63.
64. Rutkove SB, Matheson JK, Logigian EL. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve. 1996;19:670-672.
65. Krishnan PR, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord. 2003;18:181-185.
66. Poewe W, Hogl B, Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology. 2004;63(8 suppl 3):S12-S16.
67. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56:263-265.
68. Hogl B, Frauscher B, Seppi K, Ulmer H, Poewe W. Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology. 2002;59:1705-1707.
69. LaRochelle JS, Karp BI. Restless legs syndrome due to interferon-alpha. Mov Disord. 2004;19:730-731.
70. Akyol A, Kiylioglu N, Kadikoylu G, Bolaman AZ, Ozgel N. Iron deficiency anemia and restless legs syndrome: is there an electrophysiological abnormality? Clin Neurol Neurosurg. 2003;106:23-27.
71. Sevim S, Oogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry. 2004;75:226-230.
72. Takaki J, Nishi T, Nangaku M, et al. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis. 2003;41:833-839.
73. Mountifield JA. Restless leg syndrome relieved by cessation of smoking. CMAJ. 1985;133:426-427.
74. Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol. 1997;41:639-645.
75. Bucher SF, Trenkwalder C, Oertel WH. Reflex studies and MRI in the restless legs syndrome. Acta Neurol Scand. 1996;94:145-150.
76. Etgen T, Draganski B, Hg C, et al. Bilateral thalamic gray matter changes in patients with restless legs syndrome. Neuroimage. 2005;24:1242-1247.
77. Eisensehr I, Wetter TC, Linke R, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology. 2001;57:1307-1309.
78. Trenkwalder C, Walters AS, Hening WA, et ak. Positron emission tomographic studies in restless legs syndrome. Mov Disord 1999;14:141-145.
79. Turjanksi N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology. 1999;52:932-937.
80. Michaud M, Soucy JP, Chabli A, Lavigne G, Montplaisir J. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol. 2002;249:164-170.
81. Ruottinen HM, Partinen M, Hublin C, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology. 2000;54:502-507.
82. Trenkwalder C, Walters AS, Hening W. Periodic limb movements and restless legs syndrome. Neurol Clin. 1996;14:629-649.
83. von Spiczak S, Whone AL, Hammers A, et al. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain. 2005;128:906-917.
84. Rau C, Hummel F, Gerloff C. Cortical involvement in the generation of "involuntary" movements in restless legs syndrome. Neurology. 2004;62:998-1000.
85. Entezari-Taher M, Singleton JR, Jones CR, Meekins G, Petajan JH, Smith AG. Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology. 1999;53:1201-1205.
86. Tergau F, Wischer S, Paulus W. Motor system excitability in patients with restless legs syndrome. Neurology. 1999;52:1060-1063.
87. Stiasny-Kolster K, Magerl W, Oertel WH, Moller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain. 2004;127(pt 4):773-782
88. Polydefkis M, Allen RP, Hauer CJ, Griffin JW, McArthur JC. Subdinical sensory neuropathy in late-onset restless legs syndrome. Neurology. 2000;55:1115-1121.
89. Schattschneider J, Bode A, Wasner G, Binder A, Deuschl G, Baron R. Idiopathic rest-less legs syndrome: abnormalities in central somatosensory processing. J Neurol. 2004;251:977-982.
90. Beard JL, Connor JR. Iron status and neural functioning. Annu Rev Nutr. 2003;23:41-58.
91. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61:304-309.
92. Sowers JR, Vlachakis N. Circadian variation in plasma dopamine levels in man. J Endocrinol Invest. 1984;7:341-345.
93. Wang X, Wiesinger J, Beard J, et al. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome. J Neurol Sci. 2004;220:59-66.
94. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RR Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54:1698-1700.
95. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep. 1999;22:970-999.
96. Littner MR, Kushida C, Anderson WM, et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27:557-559.
97. Hening W, Allen R, Earley C, Picchietti D, Silber M. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27:560-583.
98. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry, 2004;75:92-97.
99. Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19:1414-1423.
100. Garcia-Borreguero D, Odin P, Schwarz C. Restless legs syndrome: an overview of the current understanding and management. Acta Neurol Scand. 2004;109:303-317.
101. Garcia-Borreguero D. Augmentation: understanding a key feature of RLS. Sleep Med 2004;5:5-6.